Toronto, Ontario – December 18, 2024 – Ventripoint Diagnostics Ltd. (“Ventripoint” or the “Company”), (TSXV:VPT; OTCQB:VPTDF) is pleased to announce Ventripoint and ASCEND Cardiovascular, a leading provider of cardiovascular IT solutions, have signed a term sheet defining the general terms and conditions for a non-exclusive license to Ventripoint’s VMS+ proprietary technology. The two parties expect [...]
ASCEND Cardiovascular is the leader in cardiovascular structured reporting and workflow solutions solving today’s – and anticipating tomorrow’s –
cardiovascular data accessibility and usability challenges.
